HomeVIR • NASDAQ
add
Vir Biotechnology Inc
Previous close
$10.22
Year range
$7.61 - $27.48
Market cap
1.39B USD
Avg Volume
907.39K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 56.38M | -10.45% |
Operating expense | 136.40M | 191.59% |
Net income | -65.28M | 53.67% |
Net profit margin | -115.79 | 48.26% |
Earnings per share | -0.48 | 54.72% |
EBITDA | -75.22M | 45.39% |
Effective tax rate | -0.42% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.15B | -48.90% |
Total assets | 1.79B | -32.71% |
Total liabilities | 246.61M | -64.52% |
Total equity | 1.55B | — |
Shares outstanding | 135.84M | — |
Price to book | 0.90 | — |
Return on assets | -10.78% | — |
Return on capital | -11.88% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -65.28M | 53.67% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
Apr 7, 2016
Headquarters
Website
Employees
587